THE DEAL, AT A GLANCE
From the announcementTwist Bioscience
01Who is involvedBacked by VariousFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedTwist Bioscience raised $150M Series FFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersTwist Bioscience is using its Series F financing to extend a synthetic DNA writing platform positioned for biology research and AI drug discovery.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Twist Bioscience · Financing Record
Explore source-linked visual explanations for Twist Bioscience. Unsupported claims are withheld while source review continues.
Record 668 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →